AstraZenecahas said it has cut its US drug sales by half, to half from a range of comparable products sold on the black market. The drug is the second-best-selling drug of all time in the US, behind Viagra, and has been approved by the US Food and Drug Administration (FDA) for the treatment of ADHD. Its first product, a non-stimulant medicine known as methylphenidate (Ritalin) for the treatment of attention deficit hyperactivity disorder (ADHD) in children, has been recalled because of its severe adverse reaction to the drug's active ingredient, atomoxetine HCl. The recall was also due to the recall of other drugs similar to the drug, including the antipsychotic Seroxat, which is known to cause drowsiness. AstraZeneca has also discontinued all sales of its Ritalin medicine, which has been under voluntary recall since the date of the recall. The company said that the affected products had been recalled and that the company was recalling a total of 3,500 products in the US in the fourth quarter of last year. AstraZeneca said in a statement that the recall had been "consistently effective and in line with the global standards and procedures for the safety of products". AstraZeneca is voluntarily recalling the drugs. The FDA said the product was being sold in the US to consumers under brand names, such as Strattera, Methylphenidate, and Concerta, in an amount not less than $6 million. The affected products had been sold at a retail sale in the US to consumers under brand names such as Concerta, Methylphenidate, Methylphenidate, and Methylphenidate. The affected products had been sold at a retail sale in the US to consumers under brand names such as Strattera, Methylphenidate, and Concerta, and to consumers under brand names such as Methylphenidate, Methylphenidate, and Methylphenidate. AstraZeneca said that it had not received any reports of serious adverse reactions to the affected products and that it planned to continue selling the affected products. The company said that its product recall was "finally resolved" but that the product could still be sold in the US under brand names.
Cleveland Clinic/CQ & S/O/W/P All rights reserved.Cleveland Clinic is the exclusive distributor, manufacturer and licensee of the intellectual property rights to all the drugs and medicines in the market. The rights in the drugs and medicines are also being developed by our distributors and manufacturers, and are expected to be of the most high-quality product, quality, and service. We also have a team of experienced distributors and manufacturers that are in the process of acquiring and/or expanding the rights to the drugs and medicines in the market.
Lloyds PharmacyLloyds is the exclusive distributor and licensee of the intellectual property rights to all the drugs and medicines in the market.
>Search for a specific item on our to see it. <
Strattera Generic
Strattera GenericMedication Guide
Rx medication guidesThe Rx medication guides are reviewed by our medical advisors. When comparing your medication to find the best fit for you, a doctor will review each guide independently. Our medical advisors will review each drug's label based on its strength, dosage form and brand. Our medical advisors review each drug's indications, side effects, and contraindications to ensure that the medication is safe and effective. We have resources on medical information and resources on other drugs on our website. Read on to find out more about Rx medication guides and how to choose the right one for you.
Medication Guide Information Strattera (atomoxetine) is an antidepressant that belongs to a class of drugs called selective norepinephrine reuptake inhibitors (SNRIs). Strattera is used to treat depression, attention deficit hyperactivity disorder (ADHD) in children ages 6-12, and generalized anxiety disorder (GAD) in adults. It is also used to help people who want to quit their usual antidepressants. The information provided on this website is intended to be a general guide to drug information, not a substitute for the expertise and judgment of a licensed healthcare professional. The information on this website is not intended to be a substitute for specific medical advice. Always consult your doctor or a covered health provider before starting or stopping any medication. Get your information in your head within 10 minutes and report any new or worsening symptoms. The list of drug information on this website is not exhaustive. It does have specific details about each drug, including its forms, strengths, formsuliarations, contraindications, and warnings. Your doctor will consider your specific health history, medical history, and any medications you are taking to make sure that the information on this website is as complete as the information on this website is reliable. If you have any specific questions about this website, contact your doctor or a covered health provider. This website contains only a partial description of the medication, and not a whole-tablet formulation. A complete list of the dosage, strength, forms, and brand of the medication can be found. You should not take Strattera if you are have been diagnosed with an infection after you have finished a multivitamin with vitamins C, D, and E. Your doctor will not prescribe Strattera for children under the age of 6 unless your doctor has told you that. You must continue to take Strattera as prescribed.
What is Strattera?
Strattera, also known by its generic name atomoxetine, is a selective norepinephrine reuptake inhibitor (NRRI) medication commonly prescribed to treat Attention-Deficit Hyperactivity Disorder (ADHD) and other behavioral and mood disorders. In children and adolescents, Strattera can significantly improve ADHD symptoms, but its use is limited in this population due to a lack of clinical data in this age group. Strattera is a prescription medication, and its effectiveness varies based on individual factors and dosage. It is a selective norepinephrine reuptake inhibitor (SNRI) that increases levels of norepinephrine, a neurotransmitter that plays a key role in regulating attention, impulse control, and behavior. By blocking the reuptake of norepinephrine, Strattera helps to increase the amount of norepinephrine available in the synaptic cleft, improving attention and impulse control. It also improves the ability to concentrate and avoid distractions, making it easier to focus and maintain attention. This improvement in attention and impulse control is thought to contribute to a better quality of life for ADHD children and adolescents. By increasing norepinephrine availability, Strattera helps to improve attention span and reduce impulsivity, leading to better functioning and emotional stability for the affected individuals. Additionally, Strattera is known to have a positive impact on cognitive function in ADHD children and adolescents. It is important to note that while Strattera is effective in some individuals, its effectiveness is not guaranteed for all individuals. Strattera's use in children and adolescents is often limited due to its potential side effects, including increased risk of seizures and neuropsychiatric disorders. Strattera's long half-life, which means it is more stable in the body, also means that its stability is generally more favorable than other antidepressants. This stability makes Strattera a favorable option for treating ADHD symptoms in children and adolescents. Strattera is not a selective norepinephrine reuptake inhibitor (NRRI) and should not be used in children and adolescents with a history of seizures or who have received radiation therapy for head trauma or have epilepsy. Strattera's efficacy has been demonstrated in children and adolescents with ADHD, providing support for the treatment of ADHD in children and adolescents. Strattera is generally well-tolerated and does not appear to have any serious side effects. However, it is important to note that Strattera may interact with other medications or substances, making it more difficult to use. Strattera is not a controlled substance and should not be used with other medications that are being used by individuals with ADHD or who have a history of seizures or other psychiatric conditions. In addition, Strattera has been shown to have other side effects in some individuals. In clinical trials, patients with ADHD had greater increases in their seizure scores when Strattera was used as part of a treatment plan. Strattera can cause seizures in some individuals and should not be used in children and adolescents with a history of seizures or who have had an allergic reaction to Strattera. Strattera is not an antidepressant. It is important to note that Strattera is not a controlled substance and should not be used with other medications that are being used by individuals with ADHD or who have a history of seizures or psychiatric conditions. It is not known if Strattera has any possible interactions with other medications. Strattera is not a controlled substance and should not be used with other medications that are being used by individuals with ADHD or who have a history of seizures or psychiatric conditions. In addition, Strattera is not a controlled substance and should not be used with other medications that are being used by individuals with ADHD or who have a history of seizures or psychiatric conditions. In clinical trials, patients with ADHD have a higher rate of seizures compared to children and adolescents. Strattera may also have other possible interactions with other medications, making it important to be aware of these potential interactions and to discuss them with a healthcare professional before starting treatment with Strattera. Strattera has been shown to be effective in treating ADHD in children and adolescents. The effectiveness of Strattera is not certain, but it may be an effective treatment for ADHD in children and adolescents. The most common side effects of Strattera include an increased risk of seizures and neuropsychiatric disorders, which may be associated with its use as part of a treatment plan. In addition, the safety profile of Strattera has not been established, although some studies have indicated increased risk of suicidal thoughts in children and adolescents. It should not be used in children and adolescents with a history of seizures or psychiatric conditions. Strattera may cause seizures in some individuals, but these side effects are generally mild and usually reversible upon discontinuation of the medication.
Key facts
About Strattera
Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor (SNRI) antidepressant used to treat attention deficit hyperactivity disorder (ADHD) and depression. The drug has a short-acting (STR) schedule of two weeks, starting on day 2 of the dosing schedule. This makes it an effective treatment for ADHD in children with ADHD, as well as for children and adolescents with ADHD.
How does Strattera work for ADHD?
Strattera helps to reduce ADHD symptoms, including hyperactivity, impulsive behavior, and restlessness. It is used to improve performance and improve concentration in children with ADHD. In children with ADHD, the medication is used to treat the symptoms of ADHD and depression, as well as the symptoms of other mental health conditions like depression, anxiety, and substance use. Strattera is a selective norepinephrine reuptake inhibitor (SNRI) antidepressant, which helps to reduce symptoms of ADHD.
How to use Strattera?
Strattera is a generic medication, and the brand-name drug comes in tablet form. Strattera tablets are available in strengths of 25 mg, 50 mg, 100 mg, 200 mg, and 300 mg. The dose is determined by your doctor, and you can take Strattera with or without food. It is important to take Strattera at the same time each day to maintain consistent levels of the drug in your body. Take Strattera with or without food, as it has the best absorption and reduces its potential to cause drowsiness. Strattera should be taken at least one hour before a meal. Strattera is usually taken as a single dose, and your doctor can give you the dosage in a smaller amount if necessary.
Side effects
Strattera may cause some common side effects. Common side effects may include:
Warnings
If you experience any of these symptoms, stop taking Strattera and inform your doctor immediately. Strattera is contraindicated in children, pregnant, breastfeeding, and children under 6 years old, as the drug may cause permanent damage to your hearing. You should seek immediate medical attention if you experience any unusual symptoms. Strattera should not be taken by people who have a history of allergic reactions to Strattera.
Strattera is a selective norepinephrine reuptake inhibitor (SNRI) antidepressant that is prescribed to treat attention deficit hyperactivity disorder (ADHD) and depression in children and adolescents with ADHD. It is used to treat ADHD and depression in children and adolescents with ADHD and in adults who are using Strattera to treat their symptoms.
How does Strattera work?
It is a selective norepinephrine reuptake inhibitor (SNRI) antidepressant that helps to improve performance and improve concentration in children with ADHD. It is used to treat ADHD and depression in children with ADHD and in adults who are using Strattera to treat their symptoms.
How long does it take Strattera to work?
Strattera works within several hours of administration. Strattera is usually taken once a day, with or without food.
Stade de France Pharmacy